scholarly article | Q13442814 |
P50 | author | Janet B. W. Williams | Q72206056 |
Robert Spitzer | Q653207 | ||
P2093 | author name string | Linzer M | |
Kroenke K | |||
Davies M | |||
Brody D | |||
deGruy FV 3rd | |||
Hahn SR | |||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | patient | Q181600 |
somatoform disorder | Q936549 | ||
undifferentiated somatoform disorder | Q1858000 | ||
P1104 | number of pages | 7 | |
P304 | page(s) | 352-358 | |
P577 | publication date | 1997-04-01 | |
P1433 | published in | JAMA Psychiatry | Q635830 |
P1476 | title | Multisomatoform disorder. An alternative to undifferentiated somatoform disorder for the somatizing patient in primary care | |
P478 | volume | 54 |
Q33586984 | A cross-sectional study of somatic symptoms and the identification of depression among elderly primary care patients |
Q36012127 | A method for rating charts to identify and classify patients with medically unexplained symptoms. |
Q39408480 | A qualitative analysis of explanatory models in medically unexplained physical symptoms presenting to a tertiary health care psychiatric facility in South India |
Q34628285 | A randomized clinical trial of a care recommendation letter intervention for somatization in primary care |
Q37231382 | A randomized trial of treatments for high-utilizing somatizing patients |
Q45018799 | A symptom checklist to screen for somatoform disorders in primary care |
Q35749591 | A systematic review of the epidemiology of somatisation disorder and hypochondriasis |
Q51966527 | An age-based comparison of chronic pain clinic patients. |
Q28395040 | An evaluation of SNOMED CT in the domain of complex chronic conditions |
Q44241686 | Anxiety and mood disorders in otorhinolaryngology outpatients presenting with dizziness: validation of the self-administered PRIME-MD Patient Health Questionnaire and epidemiology |
Q33579620 | Assessing medically unexplained symptoms: evaluation of a shortened version of the SOMS for use in primary care |
Q48149252 | Changes in psychosocial well-being after mindfulness-based stress reduction: a prospective cohort study |
Q92910679 | Childhood traumatization is associated with differences in TRPA1 promoter methylation in female patients with multisomatoform disorder with pain as the leading bodily symptom |
Q35753038 | Classification and diagnosis of patients with medically unexplained symptoms |
Q31156263 | Cognitive-affective neuroscience of somatization disorder and functional somatic syndromes: reconceptualizing the triad of depression-anxiety-somatic symptoms |
Q51941538 | Cognitive-behavioural therapy for patients with multiple somatoform symptoms--a randomised controlled trial in tertiary care. |
Q24235488 | Consultation letters for medically unexplained physical symptoms in primary care |
Q34870074 | Coping style in primary care adult patients with abridged somatoform disorders. |
Q40199886 | Current somatoform disorders in Norway: prevalence, risk factors and comorbidity with anxiety, depression and musculoskeletal disorders |
Q51100104 | Depressive and anxiety disorders in patients presenting with physical complaints: clinical predictors and outcome. |
Q80912828 | Determinants of complaint symptoms in a Swedish health care practice--results of a questionnaire survey |
Q34385688 | Development of mental disorders one year after exposure to psychosocial stressors; a cohort study in primary care patients with a physical complaint. |
Q37159383 | Diagnostic accuracy of predicting somatization from patients' ICD-9 diagnoses |
Q51904094 | Diagnostic classification and demographic features in 283 patients with somatoform disorder. |
Q35065268 | Differences between patients with chronic widespread pain and local chronic low back pain in primary care--a comparative cross-sectional analysis |
Q33830179 | Dissociation of regional activity in default mode network in medication-naive, first-episode somatization disorder |
Q37504661 | Economic evaluation of brief psychodynamic interpersonal therapy in patients with multisomatoform disorder |
Q43736099 | Empirical foundations for the diagnosis of somatization: implications for DSM-5. |
Q24671039 | Exploration of DSM-IV criteria in primary care patients with medically unexplained symptoms |
Q33316371 | Follow-up study on health care use of patients with somatoform, anxiety and depressive disorders in primary care |
Q21260313 | Frequency shifts in the anterior default mode network and the salience network in chronic pain disorder |
Q60935160 | Frequent attenders in general medical practice in Italy: a preliminary report on clinical variables related to low functioning |
Q74588436 | Frequent attenders without organic disease in a gastroenterology clinic. Patient characteristics and health care use |
Q36485709 | Functional network connectivity of pain-related resting state networks in somatoform pain disorder: an exploratory fMRI study |
Q26827990 | Health care utilization and poor reassurance: potential predictors of somatoform disorders |
Q42677596 | Heartsink hotel, or "Oh no, look who's on my schedule this afternoon!". |
Q92084319 | Hospitalized Patients with Medically Unexplained Physical Symptoms: Clinical Context and Economic Costs of Healthcare Management |
Q39261979 | Long-Term Outcome of Bodily Distress Syndrome in Primary Care: A Follow-Up Study on Health Care Costs, Work Disability, and Self-Rated Health |
Q48854147 | Magical thinking in somatoform disorders: an exploratory study among patients with suspected allergies |
Q34706644 | Managing the consultation with patients with medically unexplained symptoms: a grounded theory study of supervisors and registrars in general practice |
Q41685292 | Medically unexplained otorhinolaryngological symptoms: Towards integrated psychiatric care. |
Q43158651 | Medically unexplained physical symptoms |
Q24812281 | Medically unexplained physical symptoms in medical practice: a psychiatric perspective |
Q35673073 | Medically unexplained physical symptoms: toward an alternative paradigm for diagnosis and treatment |
Q34083702 | Medically unexplained symptoms: an epidemiological study in seven specialities. |
Q39266990 | Mixed emotional and physical symptoms in general practice: what diagnoses do GPs use to describe them? |
Q33630323 | Models of collaboration |
Q47674919 | Moderating Effects of Alexithymia on Associations between the Therapeutic Alliance and the Outcome of Brief Psychodynamic-Interpersonal Psychotherapy for Multisomatoform Disorder |
Q36090776 | Multiple somatic symptoms in primary care patients: a cross-sectional study of consultation content, clinical management strategy and burden of encounter |
Q43856001 | Multisomatoform disorder: agreement between patient and physician report of criterion symptom explanation |
Q38777582 | Neuroticism, alexithymia, negative affect and positive affect as predictors of medically unexplained symptoms in primary care |
Q24188129 | Non-pharmacological interventions for somatoform disorders and medically unexplained physical symptoms (MUPS) in adults |
Q24194323 | Non-pharmacological interventions for somatoform disorders and medically-unexplained physical symptoms (MUPS) in adults |
Q33693340 | Patients presenting with somatic complaints in general practice: depression, anxiety and somatoform disorders are frequent and associated with psychosocial stressors |
Q33286319 | Patients with persistent medically unexplained symptoms in general practice: characteristics and quality of care |
Q24188067 | Pharmacological interventions for somatoform disorders in adults |
Q24201668 | Pharmacological interventions for somatoform disorders in adults |
Q33754222 | Physical "phantasies" and family functions: overcoming the mind/body dualism in somatization. |
Q91591896 | Prevalence of medically unexplained symptoms in adults who are high users of health care services: a systematic review and meta-analysis protocol |
Q44594234 | Prevalence of neurasthenia, comorbidity, and association with impairment among a nationally representative sample of US adults. |
Q36112008 | Psychophysiologic treatment for patients with medically unexplained symptoms: a randomized controlled trial |
Q35721847 | Ratings of physician communication by real and standardized patients |
Q38768624 | Readiness to change as a moderator of therapy outcome in patients with somatoform disorders |
Q35480179 | Reliability of self-reported diagnoses in patients with neurologically unexplained symptoms. |
Q37642639 | Sensory neuromodulators in functional nausea and vomiting: predictors of response |
Q24673207 | Should general psychiatry ignore somatization and hypochondriasis? |
Q50637555 | Somatic symptom count scores do not identify patients with symptoms unexplained by disease: a prospective cohort study of neurology outpatients. |
Q34229353 | Somatic symptom reporting in women and men |
Q36416933 | Somatic symptoms and diseases are more common in women exposed to violence |
Q24529944 | Somatic symptoms in women 11 years after the Chornobyl accident: prevalence and risk factors |
Q37421483 | Somatisation and alexithymia in patients with high use of medical care and medically unexplained symptoms. |
Q39982770 | Somatisation disorder and its associated factors in multiethnic primary care clinic attenders |
Q41809652 | Somatisation in primary care. Solitary disclosure allows people to determine their own dose |
Q24683093 | Somatization in Family Practice: Comparing 5 Methods of Classification |
Q51079686 | Somatization in primary care: it's time for parity. |
Q49068391 | Somatization is associated with physical health-related quality of life independent of anxiety and depression in cancer, glaucoma and rheumatological disorders |
Q50675220 | Somatizing frequent attenders in primary health care. |
Q27015698 | Somatoform abdominal pain in surgery: is SD worthy of surgical attention? Case reports and literature review |
Q26829908 | Somatoform disorders and medically unexplained symptoms in primary care |
Q36384136 | Somatoform disorders: perspectives from Pakistan |
Q30559666 | Somatoform pain: a developmental theory and translational research review |
Q47712204 | The Association of Sensory Responsiveness with Somatic Symptoms and Illness Anxiety |
Q34224275 | The FIP study: a randomised, controlled trial of screening and recognition of psychiatric disorders |
Q38924576 | The Heterogeneity of Illness Behaviors in Patients with Medically Unexplained Physical Symptoms |
Q51951989 | The natural course of DSM-IV somatoform disorders and syndromes among adolescents and young adults: a prospective-longitudinal community study. |
Q34724483 | The outcomes among patients presenting in primary care with a physical symptom at 5 years. |
Q36059991 | The patient-physician relationship and medical utilization |
Q51939182 | The presence of psychiatric disorders reduces the likelihood of neurologic disease among referrals to a neurology clinic. |
Q51950582 | The somatization in primary care study: a tale of three diagnoses. |
Q33630284 | The somatizing patient |
Q74415690 | The value of screening for psychiatric disorders prior to upper endoscopy |
Q44254783 | Topiramate as a treatment for pain in multisomatoform disorder patients: an open trial |
Q47706603 | Toward empirically based criteria for the classification of somatoform disorders |
Q33824414 | Towards a clinically useful diagnosis for mild-to-moderate conditions of medically unexplained symptoms in general practice: a mixed methods study. |
Q36384105 | Towards better understanding and management of somatoform disorders |
Q36554034 | True Vertigo Patients in Emergency Department; an Epidemiologic Study |
Q73954851 | Unexplained symptoms in primary care: perspectives of doctors and patients |
Q35678803 | Use of psychopharmacological agents for functional gastrointestinal disorders |
Q51949455 | Using nurse practitioners to implement an intervention in primary care for high-utilizing patients with medically unexplained symptoms. |
Q35742960 | Validation of the PHQ-15 for somatoform disorder in the occupational health care setting |
Q36977472 | Validity of current somatoform disorder diagnoses: perspectives for classification in DSM-V and ICD-11. |
Q52354032 | [Somatoform disorders with pain as the predominant symptom: results to distinguish a common group of diseases]. |
Search more.